Company Filing History:
Years Active: 2003-2008
Title: Fred Fleitz: Innovator in Pharmaceutical Chemistry
Introduction
Fred Fleitz is a notable inventor based in Franklin Park, NJ (US), recognized for his contributions to pharmaceutical chemistry. He holds two patents that showcase his innovative approaches to drug development and synthesis.
Latest Patents
Fred Fleitz's latest patents include a process for the preparation of CCR-2 antagonists. This invention provides an efficient synthesis for the preparation of specific compounds that have significant therapeutic potential. Additionally, he has developed gamma-hydroxy-2-(fluoroalkylaminocarbonyl)-1-piperazinepentanamide compounds, which serve as inhibitors of HIV protease and replication. These compounds are crucial in the prevention and treatment of HIV infections and AIDS.
Career Highlights
Fred Fleitz is currently employed at Merck & Company, Inc., where he continues to advance his research in pharmaceutical innovations. His work has contributed to the development of effective treatments for serious health conditions.
Collaborations
Fred has collaborated with notable colleagues, including James R Tata and Kevin Tyler Chapman, to further enhance the impact of his research in the pharmaceutical field.
Conclusion
Fred Fleitz's innovative work in pharmaceutical chemistry has led to significant advancements in the treatment of HIV and AIDS. His contributions continue to shape the landscape of drug development and improve patient outcomes.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.